# Anarghya Vardhana

> Anarghya Vardhana is a venture partner at Maveron, the consumer-only VC firm co-founded by Howard Schultz, where she has spent nearly a decade backing iconic consumer brands in health, wellness, and social tech. A Stanford grad who published a math theorem at 17, she moved from Sandia National Labs nuclear research to Google international ops to the boardrooms of startups like Co-Star, Bend Health, and Alife. Forbes named her a 30 Under 30 in VC and their First Diversity Champion across the entire class. Simultaneously serving as Investor in Residence at Vanta, she is one of the few investors who credibly bridges deep technical rigor with consumer intuition - and who also runs trail marathons and dances Bharatanatyam.

- **Role:** Venture Partner at Maveron / Investor in Residence at Vanta
- **Organizations:** Maveron, Vanta, All Raise, Kauffman Fellows
- **From:** India
- **Nationality:** American (Indian-born)
- **Education:** B.S. Science, Technology, and Society (with honors); focus in Human Biology and Mathematics, Stanford University
- **Known for:** Published a mathematical theorem on number theory and prime numbers at age 17, Forbes 30 Under 30 - Venture Capital (2017), Forbes / JPMorgan Chase First Under 30 Diversity Champion Award (2017) - awarded across entire 30 Under 30 class

## Career timeline

- **2007-2008** — Department of Homeland Security Research Scholar, Sandia National Laboratories - worked on nuclear and radiation detection
- **~2010-2013** — Country Lead / Operations at Google (AdWords Express, international expansion)
- **~2013-2014** — Product Manager at Ushahidi - led UX research across South America and East Africa
- **2014-2015** — Seed-stage investor at Rothenberg Ventures (consumer and frontier tech)
- **2014-2015** — Product Manager at Medable (healthcare startup)
- **2015** — Joined Maveron as Senior Associate
- **2017** — Named Forbes 30 Under 30 in Venture Capital; awarded Forbes/JPMorgan Chase First Diversity Champion
- **2018** — Promoted to Partner at Maveron
- **2019-2021** — LinkedIn Top Voice three consecutive years
- **2022** — Published '7 Lessons for 7 Years' on Medium - reflections on VC career
- **2023** — Became Venture Partner at Maveron and Investor in Residence at Vanta (dual role)

## Achievements

- Published a mathematical theorem on number theory and prime numbers at age 17
- Forbes 30 Under 30 - Venture Capital (2017)
- Forbes / JPMorgan Chase First Under 30 Diversity Champion Award (2017) - awarded across entire 30 Under 30 class
- LinkedIn Top Voice 2019, 2020, and 2021
- Kauffman Fellow, Class 23
- DHS Research Scholar at Sandia National Laboratories (nuclear and radiation detection)
- Graduated Stanford with honors
- Led Google AdWords Express international expansion across multiple countries
- Rose from Senior Associate to General Partner to Venture Partner at Maveron over 8+ years
- Built and exits at Maveron portfolio including AllStripes, Caraway Health, Imperfect Foods
- Founded Vana, an Indian classical dance company

## Latest updates

- **2025-01** — Ran a half marathon, documented on LinkedIn, four months after a milestone personal event
- **2024-01** — Continuing dual role as Venture Partner at Maveron and Investor in Residence at Vanta
- **2023-01** — Transitioned to Venture Partner role at Maveron while adding Investor in Residence and VC Partnerships Lead role at Vanta
- **2022-11** — Published '7 Lessons for 7 Years' on Medium, reflecting on her VC career milestones
- **2022-03** — Announced Alife (women's fertility/IVF data platform) investment and joined board
- **2022-02** — Led and announced Goodbill (healthcare billing financial protection) investment

## Links

- Website: http://www.anarghyavardhana.com/
- LinkedIn: https://www.linkedin.com/in/anarghya-vardhana-b8540a27/
- Twitter/X: https://twitter.com/anarghya503
- Instagram: https://www.instagram.com/nargz503/
- Facebook: https://www.facebook.com/avardhana/

---

Profile page: https://yespress.io/anarghya-vardhana
Published by YesPress — https://yespress.io
Last updated: 2026-05-04